Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 14.10
+0.70 (5.22%)
At close: Feb 3, 2025
Central Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -36.36 | -42.42 | -43.96 | -68.25 | -8.47 | -1,107 | Upgrade
|
| Depreciation & Amortization | 24.04 | 24.04 | 26.75 | 29.76 | 32.89 | 36.28 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.59 | 10.59 | - | - | - | - | Upgrade
|
| Other Operating Activities | -9.61 | -3.04 | 0.01 | 17.47 | 21.32 | 1,070 | Upgrade
|
| Change in Accounts Receivable | 7.14 | 7.14 | -1.3 | -0.05 | -23.03 | - | Upgrade
|
| Change in Inventory | 3.8 | 3.8 | 17.12 | 20.58 | -7.41 | - | Upgrade
|
| Change in Accounts Payable | 4.21 | 4.21 | 3.79 | 0.85 | -1.39 | - | Upgrade
|
| Change in Income Taxes | 0.18 | 0.18 | 0.18 | 0.16 | 0.89 | - | Upgrade
|
| Change in Other Net Operating Assets | 4.5 | 4.5 | 1.16 | 1.07 | -5.95 | - | Upgrade
|
| Operating Cash Flow | 2.46 | 2.97 | -0.33 | -1.12 | 1.8 | -0.41 | Upgrade
|
| Capital Expenditures | - | - | - | - | -6.57 | - | Upgrade
|
| Investing Cash Flow | - | - | - | - | -6.57 | - | Upgrade
|
| Short-Term Debt Issued | - | - | - | 9.12 | - | 8.3 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 7.92 | 25.21 | 12.49 | Upgrade
|
| Total Debt Issued | - | - | - | 17.04 | 25.21 | 20.78 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 17.04 | 25.21 | 20.78 | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -11.98 | Upgrade
|
| Other Financing Activities | -0.01 | -0.01 | -0.01 | -17.47 | -21.45 | -9.98 | Upgrade
|
| Financing Cash Flow | -0.01 | -0.01 | -0.01 | -0.43 | 3.76 | -1.18 | Upgrade
|
| Net Cash Flow | 2.45 | 2.96 | -0.34 | -1.55 | -1.02 | -1.59 | Upgrade
|
| Free Cash Flow | 2.46 | 2.97 | -0.33 | -1.12 | -4.78 | -0.41 | Upgrade
|
| Free Cash Flow Margin | 35.00% | 10.02% | -1.11% | -4.31% | -3.22% | -0.29% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.02 | -0.00 | -0.01 | -0.04 | -0.00 | Upgrade
|
| Cash Interest Paid | - | - | - | 17.36 | 21.36 | 9.95 | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0.35 | 0.11 | 5.95 | 9.08 | Upgrade
|
| Levered Free Cash Flow | 15.4 | 14.59 | 17.79 | 8.19 | -19.67 | 278.09 | Upgrade
|
| Unlevered Free Cash Flow | 15.4 | 14.59 | 17.79 | 19.04 | -6.32 | 284.31 | Upgrade
|
| Change in Net Working Capital | -15.38 | -14.1 | -20.95 | -22.61 | 36.89 | -935.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.